| Related Articles |
Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer.
Oral Oncol. 2018 Dec;87:204-206
Authors: Cabezas-Camarero S, Puebla F, Subhi-Issa AI, Sanz-Ortega J, Pérez-Segura P
PMID: 30539728 [PubMed - in process]
from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2EtBYdx
No comments:
Post a Comment